For the assay of blood-clotting Factor XIII (Fibrin-Stabilizing Factor, FSF), the antibody-neutralization test (Bohn and Haupt, 1968) , the monodancylcadaverine incorporation test (Lorand et al., 1969; Nishimura et al., 1975) and the Laurell method are tried in our country (Hidano et al., 1975) . None of them, however, could be applied to the clinical screening for Factor XIII-deficient cases; the development of a simple and rapid test procedure has been awaited for.
We found that Factor XIII contained by the concentrate prepared by the Behring Institut was adsorbed to latex particles, which, then, were specifically agglutinated by rabbit anti-human Factor XIII antibody also supplied by the Behring Institut. When normal human plasma was added to the antibody prior to mixing the antibody with the antigen-coated latex particles, agglutination was no longer observed, indicating that the antibody had been consumed by its binding to the Factor XIII present in normal human plasma. For excluding any reaction attributable to subunit S, which is said to be still present in human serum after clotting had taken place and also in Factor XIII-deffcient plasma (Bohn et al., 1972) , experiments were performed exclusively by using specific antiserum against subunit A which bears Factor XIII activity.
A stock suspension of latex particles (No. 15, 0.85 p, 4.1%) supplied by Takeda Pharmaceutical Co. (Osaka, Japan) was diluted 1:10 in 0.01 M PBS (pH 7.3); it was mixed with an equal volume of Factor XIII concentrate diluted 1:5 with the same buffer. The mixture was incubated at 37 C for 2 hr. Then the latex particles were washed three times with PBS and resuspended to about 1%.
A 0.05-m1 portion of an IgG-containing fraction from rabbit anti-subunit A serum was mixed with the equal volume of a test sample and the mixture was kept at room temperature for 10 min. Then, 0.1 ml of the mixture was mixed with the equal volume of the latex reagent (antigen-coated latex particles) on a black plate. The plate was gently rocked and examined macroscopically for the presence of visible agglutination.
When visible agglutination was observed within 5 min, it was interpreted as being uninhibited by the test sam-* A part of the materials described in this note was presented at 24th General Congress of the tested every 15 min by the latex agglutination-inhibition test, no decrease in Factor XIII antigenicity was observed for 1 hr. Moreover, with the same volume of thrombin diluted with 0.1 M Veronal-HC1 buffer (pH 7.3) containing CaC12, the antigenicity did not decrease for 1 hr. Therefore, it can be seen that even when Factor XIII is activated, no such decrease occurred in its antigenicity that could be detected by the latex agglutination-inhibition test. These findings are in contrast, on one hand, to the paradoxical observation by Miura (1975) in the immunodiffusion technique that even human serum formed a clear precipitation band against anti-subunit A serum; on the other hand, to the findings by the staff of the First Department of Medicine, Teikyo University (personal communication) that Factor XIII antigenicity in the Laurell method disappeared upon its activation by thrombin and calcium ion.
